---
title: "WuXi Biologics (WXXWY.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/WXXWY.US/norm.md"
symbol: "WXXWY.US"
name: "WuXi Biologics"
parent: "https://longbridge.com/en/quote/WXXWY.US.md"
datetime: "2026-05-19T18:57:20.546Z"
locales:
  - [en](https://longbridge.com/en/quote/WXXWY.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/WXXWY.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/WXXWY.US/norm.md)
---

# WuXi Biologics (WXXWY.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.0871 | 0.0856 | 0.0769 | 0.0760 | 0.0599 |
| ROE | 10.87% | 11.15% | 10.41% | 10.78% | 8.88% |
| Revenue | 845.97M | 831.31M | 693.89M | 685.12M | 691.93M |
| Net income | 183.61M | 180.43M | 163.08M | 161.02M | 127.20M |
| Operating income | 280.32M | 275.46M | 189.92M | 187.52M | 189.46M |
| Gross margin | 48.71% | 48.71% | 42.73% | 42.73% | 42.58% |
| Net margin | 21.70% | 21.70% | 23.50% | 23.50% | 18.38% |
| Profit quality | 86.50% | 86.50% | 150.78% | 150.78% | 70.64% |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 9.10B | 8.95B | 8.43B | 8.32B | 7.81B |
| Leverage | 1.20 | 1.20 | 1.23 | 1.23 | 1.25 |
| BVPS | 3.27 | 3.21 | 3.08 | 3.04 | 2.79 |
| Turnover | 0.3611 | 0.3468 | 0.3442 | 0.3323 | 0.3289 |
| Cash & STI | 2.25B | 2.21B | 1.75B | 1.73B | 1.47B |
| Inv & Rec | 197.44M | 194.01M | 230.76M | 227.85M | 208.47M |
| LT assets | 4.25B | 4.18B | 4.21B | 4.15B | 3.90B |
| Net debt | -1.81B | -1.77B | -1.04B | -1.02B | -790.48M |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 324.05M | 318.44M | 125.96M | 124.37M | 268.19M |
| Investing CF | -182.17M | -179.01M | -37.52M | -37.05M | -243.80M |
| Financing CF | -77.07M | -75.74M | -75.68M | -74.72M | -87.31M |
| Free CF | 124.16M | 269.88M | 78.47M | 140.51M | 56.82M |
| OCF coverage | 121.68% | 121.68% | 63.17% | 63.17% | 160.15% |
| Repaid & issued | 11.45M | 11.25M | 67.05M | 66.20M | 52.19M |
| CapEx | -127.55M | -125.34M | -132.49M | -130.81M | -141.26M |